{"id":"W4404532483","doi":"10.1093/bjd/ljae454","title":"Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novartis Portugal; Janssen Australia; Caisse nationale de l'Assurance Maladie; Bristol-Myers Squibb Canada; AbbVie Canada; Psoriasis Association; LEO Pharma; Assistance publique-Hôpitaux de Paris; Cilag; University of Manchester; British Association of Dermatologists; Almirall; Boehringer Ingelheim España; Assistance Publique - Hôpitaux de Paris; Manchester Biomedical Research Centre","keywords":"Biosimilar; Adalimumab; Medicine; Psoriasis; Multinational corporation; Cohort; Internal medicine; Cohort study; Oncology; Family medicine; Dermatology; Business; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009483469,0.0007539917,0.001245037,0.001075134,0.0006428475,0.001328194,0.0009639871,0.0009535117,0.002096504],"category_scores_gemma":[0.01035958,0.0005374902,0.004779442,0.00226984,0.0003970528,0.0006702091,0.00080982,0.001104241,0.000272234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006964361,"about_ca_system_score_gemma":0.0007334858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004719395,"about_ca_topic_score_gemma":0.003691017,"domain_scores_codex":[0.9955873,0.001863488,0.0004991823,0.001238025,0.0005817291,0.0002301106],"domain_scores_gemma":[0.9866619,0.002858068,0.005508815,0.003291572,0.0009694899,0.0007101637],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01675018,0.0002816101,0.9597088,0.0002426344,0.0178583,0.0001290415,0.0001638338,0.0002411649,0.0005225118,0.0000529773,0.0004132326,0.003635818],"study_design_scores_gemma":[0.002907022,0.002359746,0.974195,0.00009827095,0.01738399,0.0004553112,0.0001698516,0.001001738,0.0002816577,0.0001110464,0.0009910931,0.0000452799],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995226,0.002398443,0.0003021916,0.0000608901,0.00002551107,0.00005756416,0.001712607,0.000007034935,0.0002097143],"genre_scores_gemma":[0.9968646,0.0006716961,0.0002663878,0.00008779236,0.00003270106,0.00007462546,0.001814772,0.000008240414,0.0001791856],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009483469,"threshold_uncertainty_score":0.05015397,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01359610410727565,"score_gpt":0.2890731079822312,"score_spread":0.2754770038749556,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}